期刊文献+

PPARγ激动剂干预对激活星形胶质细胞Jagged1的影响

Effect of PPARγ agonist on Jagged1 mRNA expression in activated astrocytes
原文传递
导出
摘要 目的观察过氧化物酶体增殖物激活受体γ(PPARγ)激动剂吡格列酮干预对激活星形胶质细胞产生Jagged1的影响。方法采用脂多糖(LPS)刺激纯化的星形胶质细胞,将不同梯度浓度吡格列酮(0.01,0.1,1.0,10.0μm)和转化生长因子β1(10 ng/ml)共刺激星形胶质细胞6 h,提取细胞RNA。结果吡格列酮呈浓度依存性抑制LPS激活星形胶质细胞中Jagged1的mRNA表达(P<0.05)。结论吡格列酮抑制星形胶质细胞Jagged1的产生,Jagged1/Notch通路的激活可能随之减弱,有利于多发性硬化的髓鞘修复。 Objective To investigate the effect of peroxisome proliferator-activated receptor-gamma(PPARγ) agonist on Jagged1 mRNA expression in activated astrocytes.Methods Astrocyte activated by LPS was treated by pioglitazone with different concentrations(0.01,0.1,1.0,10.0 μm)and TGF-β1(10 ng/ml) for 6 hours.Then the Jagged1 mRNA was extracted and the expression of Jagged1 mRNA was evaluated with fluorescent quantixative RT-PCR.Results Pioglitazone inhibited the Jagged1 mRNA expression of astrocytes in a concentration-dependent manner(P〈0.05).Conclusion Pioglitazone inhibits Jagged1 mRNA expression of astrocytes,which leads to reducing the activation of Jagged1/Notch1 pathway and facilitating the repair of myelin sheath of multiple sclerosis.
出处 《江苏医药》 CAS CSCD 北大核心 2011年第15期1737-1739,共3页 Jiangsu Medical Journal
基金 江苏省卫生厅"135"工程重点学科基金(200131) 江苏省高校自然科学研究计划自筹经费项目(08KJD320004)
关键词 过氧化物酶体增殖物激活受体Γ 星形胶质细胞 Jaggedl基因 转化生长因子Β1 Peroxisome proliferator-activated receptor-gamma Astrocyte Jagged1 gene Transforming growth factor-β1
  • 相关文献

参考文献12

  • 1Aharoni R, Herschkovitz A, Eilam R, et al. Demyelina- tion arrest and remyelination induced by glatirarner acetatetreatment of experimental autoimmune encephatomyelitis[J]. Proc Natl Acad Sci USA,2008,105(32):11358-11363.
  • 2Blakemore WF. Regeneration and repair in multiple sclemais: the view of experimental pathology[J].J Neurol Sci, 2008, 265(2) : 1-4.
  • 3Jurynczyk M, Jurewicz A, Bielecki B, et al. Overcoming failure to repair demyelination in EAE:garnma-secretase inhi- bition of Notch signaling[J]. J Neurol Sci, 2008,265 (2) : 5- 11.
  • 4Seifert T, Bauer J, Weissert R, et al. Notch1 and its ligand Jagged1 are present in remyelination in a T-cell- and antibody- mediated model of inflammatory demyelination [J ]. Acta Neuropathol, 2007,113(2) : 195-203.
  • 5Szeles L, Torocsik D, Nagy L. PPARgamma in immunity and inflammation., ceU types and diseases[J]. Biochim Biophys Acta, 2007,1771(8) : 1014-1030.
  • 6Narala VR, Ranga R, Smith MR, et al. Pioglitazone is as effective as dexamethasone in a cockroach allergen-induced murine model of asthrna[J]. Respir Res, 2007,8 (1) : 90.
  • 7Wang W, Liu F, Chen N. Peroxisome proliIerator-activated receptor-gamma (PPAR-gamrna) agonists attenuate the profibrotie response induced by TGF-betal in renal interstitial fibroblasts[J]. Mediators Inflamm,2007,2007(lllS):62641- 62647.
  • 8Ghosh AK, Wei J, Wu M, et ak Constitutive Smad signaling and Smad-dependent collagen gene expression in mouse embryonic fibroblasts lacking peroxisome proliferator- activated receptor-gamma[J]. Biochem Biophys Res Commun, 2008,374(2) : 231-236.
  • 9Kulkarni AA, Thatcher TH, Olsen KC, et al. PPAR-y ligands repress TGFninduced myofibroblast differentiation by targe- ting the PI3K/Akt pathway: implications for therapy of fibrosis[J]. PLoS One,2011,6(1) : 15909-15914.
  • 10Sethi N, Dai X, Winter CG, et al. Tumor-derived JAGGED1 promotes osteolytie bone metastasis of breast cancer by engaging notch signaling in bone cells[J]. Cancer Cell, 2011, 19(2):192-205.

二级参考文献35

  • 1Zhang Y, Zhang J, Navrazhina K, et al. TGFbetal induces Jagged1 expression in astrocytes via ALK5 and Smad3 and regulates the balance between oligodendrocyte progenitor proliferation and differentiation[J]. Glia, 2010, 58(8) : 964- 974.
  • 2Zhang Y, Argaw AT, Gurfein BT, et al. Notch1 signaling plays a role in regulating precursor differentiation during CNS[J]. Proc Natl Acad Sci, 2009, 106(45): 19162-19167.
  • 3Seifert T, Bauer J, Weissert R, et al. Notchl and its ligand Jagged1 are,present in remyelination in a T-cell- and antibody-mediated model of inflammatory demyelination[J]. Acta Neuropathol, 2007, 113(2) :195-203.
  • 4John GR, Shankar SL, Shafit-Zagardo B, et al. Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation[J]. Nat Med, 2002, 8 (10): 1115-1121.
  • 5Tripathi RB, Rivers LE, Young KM, et al. NG2 glia generate new oligodendroeytes hut few astrocytes in a murine experimental autoimmune encephalomyelitis model of demyelinating disease[J]. J Neurosci, S010, 30 (48): 16383- 16389.
  • 6Chari DM. Remyelination in multiple sclerosis[J]. Int Rev Neurobiol, 2007, 79(1) :589-620.
  • 7Aharoni R, Herschkovitz A, Eilam R, et al. Demyelination arrest and remyelination induced by glatiramer acetate treatment of experimental autoimmune encephalomyelitis [J ]. Proc Natl Aead Sci, 2008, 105(32):11358-11363.
  • 8Seifert T, Bauer J, Weissert R, et al. Notch1 and its ligand Jaggedl are present in remyelination in a T-cell- and antibody-mediated model of inflammatory demyelination[J]. Acta Neuropathol, 2007, 113(2) : 195-203.
  • 9Jurynczyk failure to M, Jurewicz A, Bielecki B, et al. Overcoming repair demyelination in EAE: gamma-secretase inhibition of Notch signaling[J]. J Neurol Sci, 2008, 265 (2) :5-11.
  • 10Zhao C, Fancy SP, Kotter MR, et al. Mechanisms of CNS remyelination-the key to therapeutic advances. J Neurol Sci, 2005,233 ( 1-2 ) :1 87-91.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部